Literature DB >> 8993429

Protection of rat retina from ischemia-reperfusion injury by vasoactive intestinal peptide (VIP): the effect of VIP on lipid peroxidation and antioxidant enzyme activity of retina and choroid.

N Tunçel1, H Başmak, K Uzuner, M Tunçel, G Altiokka, V Zaimoğlu, A Ozer, F Gürer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8993429     DOI： 10.1111/j.1749-6632.1996.tb17509.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  8 in total

1.  Degree of damage compensation by various PACAP treatments in monosodium glutamate-induced retinal degeneration.

Authors:  Norbert Babai; Tamás Atlasz; Andrea Tamás; Dóra Reglödi; Gábor Tóth; Péter Kiss; Róbert Gábriel
Journal:  Neurotox Res       Date:  2005-11       Impact factor: 3.911

2.  Effects of PACAP in UV-A radiation-induced retinal degeneration models in rats.

Authors:  Tamas Atlasz; Krisztina Szabadfi; Peter Kiss; Zsuzsanna Marton; Monika Griecs; Levente Hamza; Valeria Gaal; Zsolt Biro; Andrea Tamas; Gabor Hild; Miklos Nyitrai; Gabor Toth; Dora Reglodi; Robert Gabriel
Journal:  J Mol Neurosci       Date:  2010-06-03       Impact factor: 3.444

3.  VIP-Related protection against lodoacetate toxicity in pheochromocytoma (PC12) cells: a model for ischemic/hypoxic injury.

Authors:  E Sigalov; M Fridkin; D E Brenneman; I Gozes
Journal:  J Mol Neurosci       Date:  2000-12       Impact factor: 3.444

4.  Antioxidant and anti-apoptotic activity of vasoactive intestinal peptide (VIP) against 6-hydroxy dopamine toxicity in the rat corpus striatum.

Authors:  Neşe Tunçel; Orhan Tansel Korkmaz; Neslihan Tekin; Erol Şener; Fahrettin Akyüz; Mine Inal
Journal:  J Mol Neurosci       Date:  2011-08-18       Impact factor: 3.444

5.  Vasoactive intestinal peptide enhances striatal plasticity and prevents dopaminergic cell loss in Parkinsonian rats.

Authors:  OrhanTansel Korkmaz; Hakan Ay; Emel Ulupinar; Neşe Tunçel
Journal:  J Mol Neurosci       Date:  2012-04-29       Impact factor: 3.444

6.  Protective effects of vasoactive intestinal peptide (VIP) in ischemic retinal degeneration.

Authors:  K Szabadfi; B Danyadi; P Kiss; A Tamas; E Fabian; R Gabriel; D Reglodi
Journal:  J Mol Neurosci       Date:  2012-04-29       Impact factor: 3.444

7.  The Protective Role of PAC1-Receptor Agonist Maxadilan in BCCAO-Induced Retinal Degeneration.

Authors:  A Vaczy; D Reglodi; T Somoskeoy; K Kovacs; E Lokos; E Szabo; A Tamas; T Atlasz
Journal:  J Mol Neurosci       Date:  2016-08-26       Impact factor: 3.444

Review 8.  Relationships Between Neurodegeneration and Vascular Damage in Diabetic Retinopathy.

Authors:  Maria Grazia Rossino; Massimo Dal Monte; Giovanni Casini
Journal:  Front Neurosci       Date:  2019-11-08       Impact factor: 4.677
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.